SCA Pharmaceuticals Recalls Morphine Sulfate Bags Due to Sterility Concerns
SCA Pharmaceuticals is recalling 220 bags of morphine sulfate in 0.9% sodium chloride because the product was made with recalled saline bags that may leak, compromising sterility.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a high-risk medication (morphine) with a potential sterility breach, which poses a risk of harm (infection) even though no specific injuries or illnesses are reported in the source text.
Plain-English summary
SCA Pharmaceuticals is recalling 220 bags of morphine sulfate 1 mg per mL in 0.9% Sodium Chloride. The product is a 100 mL single-dose container bag labeled as NDC 70004-0100-59 and NDC 70004-100-58. The recall is due to a lack of assurance of sterility, as the product was manufactured using recalled 0.9% sodium chloride bags that have the potential to leak.
The affected lots are 20170707@34 (BUD: 10/5/2017), 20170710@21 (BUD: 10/8/2017), and 20170706@44 (BUD: 10/4/2017). The product was distributed nationwide in the USA. The FDA has classified this recall as Class II.
Healthcare providers and patients should stop using the affected product and contact SCA Pharmaceuticals at (877) 550-5059 for further instructions. The recall is voluntary and precautionary to ensure patient safety regarding sterility.
The recalled product
- Product
- morphine sulfate 1 mg per mL in 0.9% Sodium Chloride, (Total morphine Dose 100 mg/100 mL), Total Volume 100 mL Single Dose Container bag, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct, Little Rock, AR 72205, (877) 550-5059; labeled as a) NDC: 70004-0100-59; b) NDC: 70004-100-58.
- Manufacturer
- SCA Pharmaceuticals
- Category
- Drug — Injectable Medication
- Hazard
- Affected units
- 220
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lots: a) 20170707@34
- BUD:10/5/2017
- 20170710@21
- BUD: 10/8/2017
- b) 20170706@44
- BUD: 10/4/2017
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 6 recalled by SCA Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · SCA Pharmaceuticals
See all →- HighSCA Pharmaceuticals Fentanyl-Bupivacaine Injectable Recall Due to Manufacturing Deviations
FDA (Drugs) · 2023-08-02
- ModerateFDA recalls Oxytocin product for low potency nationwide
FDA (Drugs) · 2023-05-03
- ModerateFentanyl Injection Syringes Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2023-03-08
- ModerateNorepinephrine Injection Recalled Nationwide for Manufacturing Quality Deviations
FDA (Drugs) · 2022-05-11
- ModerateDrug recall: fentanyl and bupivacaine injectable solution manufacturing deviations
FDA (Drugs) · 2022-05-11
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29